Treatment of Hospital-Onset COVID-19 in Adults and Children, DHSC (updated 28th November 2022)

The published policy has been updated to reflect updated WHO guideline, latest evidence& extension of remdesevir marketing authorisation. Treatments choices are now nirmatrelvir/ritonavir (Paxlovid) (1st line) or remdesivir (2nd line). Exceptionally, sotrovimab may be considered
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news